20/20 BioLabs Overview
- Year Founded
-
2000
- Status
-
Public
- Employees
-
14
- Stock Symbol
-
AIDX
- Share Price
-
$0.20
- (As of Friday Closing)
20/20 BioLabs General Information
Description
20/20 Biolabs Inc is a commercial stage diagnostics company with the core mission of developing and commercializing clinical laboratory tests for early disease detection and prevention and associated software that is powered by machine learning and real-world data to improve diagnostic accuracy and clinical utility. The company offers two OneTest lab products; OneTest for Cancer that inludes primary MCED blood test and revenue source post-COVID and OneTest for Longevity that consists of inflammatory biomarkers.
Contact Information
Website
www.2020biolabs.comCorporate Office
- 15810 Gaither Road
- Suite 235
- Gaithersburg, MD 20877
- United States
Corporate Office
- 15810 Gaither Road
- Suite 235
- Gaithersburg, MD 20877
- United States
20/20 BioLabs Stock Performance
As of 13-Nov-2026, 20/20 BioLabs’s stock price is $0.20. Its current market cap is $2.73M with 13.4M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $0.20 | $0.20 | $0.18 - $50.00 | $2.73M | 13.4M | 139K | -$0.75 |
20/20 BioLabs Financials Summary
As of 30-Jun-2026, 20/20 BioLabs has a trailing 12-month revenue of $2.04M.
|
In Thousands, USD |
TTM 30-Jun-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 3,645 | |||
| Revenue | 2,040 | 2,045 | 1,752 | 1,424 |
| EBITDA | (5,081) | (3,526) | (5,483) | (6,405) |
| Net Income | (5,814) | (3,739) | (5,552) | (6,391) |
| Total Assets | 6,123 | 4,137 | 3,584 | 6,368 |
| Total Debt | 572 | 1,359 | 840 | 1,233 |
20/20 BioLabs Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
20/20 BioLabs Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price |
% Owned |
|---|
20/20 BioLabs Comparisons
Industry
Financing
Details
20/20 BioLabs Competitors (38)
One of 20/20 BioLabs’s 38 competitors is Biodesix, a Formerly VC-backed company based in Louisville, CO.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Biodesix | Formerly VC-backed | Louisville, CO | ||||
| Guardant Health | Formerly VC-backed | Palo Alto, CA | ||||
| Agendia | Venture Capital-Backed | Irvine, CA | ||||
| Asuragen | Formerly VC-backed | Austin, TX | ||||
| Epigenomics | Formerly VC-backed | Heidelberg, Germany |
20/20 BioLabs Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
20/20 BioLabs Patents
20/20 BioLabs Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20230263477-A1 | Universal pan cancer classifier models, machine learning systems and methods of use | Pending | 13-Jul-2020 | ||
| WO-2022015700-A1 | Universal pan cancer classifier models, machine learning systems and methods of use | Inactive | 13-Jul-2020 | ||
| US-20230223145-A1 | Methods and software systems to optimize and personalize the frequency of cancer screening blood tests | Pending | 01-Jun-2020 | ||
| WO-2021247577-A1 | Methods and software systems to optimize and personalize the frequency of cancer screening blood tests | Inactive | 01-Jun-2020 | ||
| US-20200005901-A1 | Cancer classifier models, machine learning systems and methods of use | Inactive | 30-Jun-2018 | G16H50/70 |
20/20 BioLabs Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
20/20 BioLabs FAQs
-
When was 20/20 BioLabs founded?
20/20 BioLabs was founded in 2000.
-
Where is 20/20 BioLabs headquartered?
20/20 BioLabs is headquartered in Gaithersburg, MD.
-
What is the size of 20/20 BioLabs?
20/20 BioLabs has 14 total employees.
-
What industry is 20/20 BioLabs in?
20/20 BioLabs’s primary industry is Diagnostic Equipment.
-
Is 20/20 BioLabs a private or public company?
20/20 BioLabs is a Public company.
-
What is 20/20 BioLabs’s stock symbol?
The ticker symbol for 20/20 BioLabs is AIDX.
-
What is the current stock price of 20/20 BioLabs?
As of 13-Nov-2026 the stock price of 20/20 BioLabs is $0.20.
-
What is the current market cap of 20/20 BioLabs?
The current market capitalization of 20/20 BioLabs is $2.73M.
-
What is 20/20 BioLabs’s current revenue?
The trailing twelve month revenue for 20/20 BioLabs is $2.04M.
-
Who are 20/20 BioLabs’s competitors?
Biodesix, Guardant Health, Agendia, Asuragen, and Epigenomics are some of the 38 competitors of 20/20 BioLabs.
-
What is 20/20 BioLabs’s annual earnings per share (EPS)?
20/20 BioLabs’s EPS for 12 months was -$0.75.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
